BindingDB logo
myBDB logout

null

SMILES: C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F

InChI Key: InChIKey=FIDCOOGXAYYGDL-WRCLSMMLSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 494880   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Ketohexokinase


(Homo sapiens (Human))
BDBM494880
PNG
(US10988463, Example 24 | [(1R,5S,6R)-3-{2-[(2S,3R)...)
Show SMILES C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F
Show InChI InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.70n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
Assay A, a 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepa...


US Patent US10988463 (2021)

More data for this
Ligand-Target Pair
Ketohexokinase


(Homo sapiens (Human))
BDBM494880
PNG
(US10988463, Example 24 | [(1R,5S,6R)-3-{2-[(2S,3R)...)
Show SMILES C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F
Show InChI InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.30n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
Assay B, using 10-fold less enzyme and measuring absorbance for 3 hours to obtain IC50 values below the 10 nM lower limit of Assay A. Compounds were ...


US Patent US10988463 (2021)

More data for this
Ligand-Target Pair
Ketohexokinase


(Homo sapiens (Human))
BDBM494880
PNG
(US10988463, Example 24 | [(1R,5S,6R)-3-{2-[(2S,3R)...)
Show SMILES C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F
Show InChI InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 9.70n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
Assay A, a 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepa...


US Patent US10988463 (2021)

More data for this
Ligand-Target Pair
Isoform A of Ketohexokinase (Peripheral)


(Homo sapiens (Human))
BDBM494880
PNG
(US10988463, Example 24 | [(1R,5S,6R)-3-{2-[(2S,3R)...)
Show SMILES C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F
Show InChI InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 12.1n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Compounds were prepared in DMSO as...


US Patent US10988463 (2021)

More data for this
Ligand-Target Pair
Ketohexokinase


(Homo sapiens (Human))
BDBM494880
PNG
(US10988463, Example 24 | [(1R,5S,6R)-3-{2-[(2S,3R)...)
Show SMILES C[C@H]1[C@H](O)CN1c1nc(c(C)c(n1)C12CNCC1C2CC(O)=O)C(F)(F)F
Show InChI InChI=1S/C17H21F3N4O3/c1-7-13(16-6-21-4-10(16)9(16)3-12(26)27)22-15(23-14(7)17(18,19)20)24-5-11(25)8(24)2/h8-11,21,25H,3-6H2,1-2H3,(H,26,27)/t8-,9?,10?,11+,16?/m0/s1
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 11n/an/an/an/an/an/a



Pfizer Inc.

US Patent


Assay Description
Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physiological concentrations of the nat...


US Patent US10988463 (2021)

More data for this
Ligand-Target Pair